Teva: Is Another Dividend Cut In The Cards?
October 25, 2017 at 18:10 PM EDT
Through the first half of 2017 Teva's free cash flow has free fallen. The company recently cut its dividend to stem cash burn. Generic Copaxone could cause free cash flow to turn negative. Is another dividend cut in the cards?
